Suchergebnisse - "Talamonti, Marina"

PubPharm (102)

1

Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab

enthalten in: Dermatitis : contact, atopic, occupational, drug | 2024

von Russo, F. | Cioppa, V. | Lazzeri, L. | +12

2

Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema : A Retrospective Study

enthalten in: Journal of clinical medicine | 2024

von Paganini, C. | Maffei, V. | Vellucci, L. | +6

3

Tildrakizumab : the value of a personalized and flexible approach for treating moderate-to-severe plaque psoriasis in patients with high body weight or high disease burden

enthalten in: Expert opinion on biological therapy | 2024

von Dapavo, P. | Burlando, M. | Guarneri, C. | +4

4

Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors : A case series

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Gori, N. | Ippoliti, E. | Ferrucci, S. | +24

5

Successful long-term guselkumab treatment of severe plaque psoriasis in patients with class III obesity : A case series

enthalten in: Skin health and disease | 2024

von Galluzzo, M. | Marcelli, L. | Fico, A. | +2

6

Dupilumab for Treatment of Prurigo Nodularis : Real-Life Effectiveness for up to 84 Weeks

enthalten in: Journal of clinical medicine | 2024

von Paganini, C. | Talamonti, M. | Maffei, V. | +3

7

Successful long‐term guselkumab treatment of severe plaque psoriasis in patients with class III obesity : A case series

enthalten in: Skin Health and Disease | 2024

von Galluzzo, M. | Marcelli, L. | Fico, A. | +2

8

Letter in response to the case report : "Recalcitrant generalized granuloma annulare treated successfully with dupilumab"

enthalten in: JAAD case reports | 2023

von Paganini, C. | Talamonti, M. | Campione, E. | +2

9

Deucravacitinib, a selective tyrosine kinase 2 inhibitor, for the treatment of moderate-to-severe plaque psoriasis

enthalten in: Expert opinion on pharmacotherapy | 2023

von Galluzzo, M. | Vellucci, L. | Marcelli, L. | +3

10

Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab : A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS)

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von Gargiulo, L. | Ibba, L. | Malagoli, P. | +21

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]